Menovo Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 2,370

Employees

  • Stock Symbol
  • 603538

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $3.20
  • (As of Thursday Closing)

Menovo General Information

Description

Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.

Contact Information

Website
www.menovopharm.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Floor 12B, Building 1, Ningbo R&D Park, Lane 999
  • Yangfan Road, High-tech Zone
  • Ningbo, Zhejiang 315040
  • China
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHG
Vertical(s)
Manufacturing
Corporate Office
  • Floor 12B, Building 1, Ningbo R&D Park, Lane 999
  • Yangfan Road, High-tech Zone
  • Ningbo, Zhejiang 315040
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Menovo Stock Performance

As of 12-Nov-2026, Menovo’s stock price is $3.20. Its current market cap is $1.09B with 340M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.20 $3.29 $1.92 - $7.38 $1.09B 340M 40.2M $0.03

Menovo Financials Summary

As of 30-Sep-2026, Menovo has a trailing 12-month revenue of $265M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,484,144 706,639 479,822 649,899
Revenue 265,068 209,019 191,326 171,946
EBITDA 21,978 41,115 36,377 21,198
Net Income 16,021 14,216 9,310 1,638
Total Assets 713,355 693,524 637,145 624,032
Total Debt 118,054 214,779 183,768 183,740
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Menovo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Menovo‘s full profile, request access.

Request a free trial

Menovo Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Menovo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020248341-A1 Method for preparing valsartan Inactive 13-Jun-2019

Menovo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Menovo Investments & Acquisitions (7)

Menovo’s most recent deal was a Later Stage VC with Jiangsu Meike Medical Technology. The deal was made on 08-Mar-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Jiangsu Meike Medical Technology 08-Mar-2022 Later Stage VC Diagnostic Equipment
Inhal Pharma 31-Dec-2020 Early Stage VC Other Pharmaceuticals and Biotechnology
Liaoyuan Pharmaceutical 23-Jul-2018 Secondary Transaction - Private Medical Supplies
Ningbo Krka Menovo 05-Dec-2017 Joint Venture Therapeutic Devices
Liaoyuan Pharmaceutical 12-Sep-2017 Merger/Acquisition Medical Supplies
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Menovo ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Menovo’s complete esg history, request access »

Menovo Exits (3)

Menovo’s most recent exit was on 23-Jul-2018 from Liaoyuan Pharmaceutical. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Liaoyuan Pharmaceutical 23-Jul-2018 Completed
Liaoyuan Pharmaceutical 12-Sep-2017 Completed
Liaoyuan Pharmaceutical 10-Apr-2015 Corporate Completed
To view Menovo’s complete exits history, request access »

Menovo FAQs

  • When was Menovo founded?

    Menovo was founded in 2004.

  • Where is Menovo headquartered?

    Menovo is headquartered in Ningbo, China.

  • What is the size of Menovo?

    Menovo has 2,370 total employees.

  • What industry is Menovo in?

    Menovo’s primary industry is Pharmaceuticals.

  • Is Menovo a private or public company?

    Menovo is a Public company.

  • What is Menovo’s stock symbol?

    The ticker symbol for Menovo is 603538.

  • What is the current stock price of Menovo?

    As of 12-Nov-2026 the stock price of Menovo is $3.20.

  • What is the current market cap of Menovo?

    The current market capitalization of Menovo is $1.09B.

  • What is Menovo’s current revenue?

    The trailing twelve month revenue for Menovo is $265M.

  • What is Menovo’s annual earnings per share (EPS)?

    Menovo’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process